Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management

키워드

참고문헌 (62)

1. Jaacks LM, "The obesity transition : stages of the global epidemic", Lancet Diabetes Endocrinol, 7, pp.231~240 (2019)
2. Harrison SA, "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middleaged US cohort", J Hepatol, 75, pp.284~291 (2021)
3. 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
4. Jaejun Lee, "Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population- based cross-sectional study", Clinical and Molecular Hepatology, 28(2), pp.196~206 (2022), 대한간학회[DOI]
5. Wong RJ, "Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U. S", Hepatology, 59, pp.2188~2195 (2014)
6. Adam R, "2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation", Transpl Int, 31, pp.1293~1317 (2018)
7. Theresa J. Hydes, "Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH", Clinical and Molecular Hepatology, 26(4), pp.383~400 (2020), 대한간학회[DOI]
8. Vilar-Gomez E, "Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis", Gastroenterology, 149, pp.367~378 (2015)
9. Promrat K, "Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis", Hepatology, 51, pp.121~129 (2010)
10. Lefere S, "Intensive lifestyle management improves steatosis and fibrosis in pediatric nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 20, pp.2317~2326 (2022)
11. Dudekula A, "Weight loss in nonalcoholic fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits", PLoS One, 9, pp.e111808~ (2014)
12. Buchwald H, "The evolution of metabolic", bariatric surgery, 2014, pp.24, 1126~1135
13. Cardoso L, "Short-and longterm mortality after bariatric surgery : a systematic review and meta-analysis", Diabetes Obes Metab, 19, pp.1223~1232 (2017)
14. Svane MS, "Postprandial nutrient handling and gastrointestinal hormone secretion after Roux-en-Y gastric bypass vs sleeve gastrectomy", Gastroenterology, 156, pp.1627~1641 (2019)
15. Kohli R, "Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids", J Clin Endocrinol Metab, 98, pp.E708~E712 (2013)
16. Lefere S, "Bariatric surgery and the liver-mechanisms, benefits, and risks", Obes Rev, 22, pp.e13294~ (2021)
17. Sjöström L, "Effects of bariatric surgery on mortality in Swedish obese subjects", N Engl J Med, 357, pp.741~752 (2007)
18. Adams TD, "Long-term mortality after gastric bypass surgery", N Engl J Med, 357, pp.753~761 (2007)
19. Schauer PR, "Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes", N Engl J Med, 376, pp.641~651 (2017)
20. Wiggins T, "Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level : a systematic review and meta-analysis", PLoS Med, 17, pp.e1003206~ (2020)
21. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
22. Subichin M, "Liver disease in the morbidly obese : a review of 1000consecutive patients undergoing weight loss surgery", Surg Obes Relat Dis, 11, pp.137~141 (2015)
23. Mahawar KK, "Routine liver biopsy during bariatric surgery : an analysis of evidence base", Obes Surg, 26, pp.177~181 (2016)
24. Rheinwalt KP, "Baseline presence of NAFLD predicts weight loss after gastric bypass surgery for morbid obesity", J Clin Med, 9, pp.3430~ (2020)
25. Soresi M, "The prevalence of NAFLD and fibrosis in bariatric surgery patients and the reliability of noninvasive diagnostic methods", Biomed Res Int, 2020, pp.5023157~ (2020)
26. Froylich D, "Factors associated with length of stay in intensive care after bariatric surgery", Surg Obes Relat Dis, 12, pp.1391~1396 (2016)
27. von Schönfels W, "Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS(NAFLD activity score)", Surg Obes Relat Dis, 14, pp.1607~1616 (2018)
28. Lee Y, "a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 17, pp.1040~1060 (2019)
29. Lassailly G, "Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients", Gastroenterology, 149, pp.379~388 (2015)
30. Fakhry TK, "Bariatric surgery improves nonalcoholic fatty liver disease : a contemporary systematic review and meta-analysis", Surg Obes Relat Dis, 15, pp.502~511 (2019)
31. Lassailly G, "Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis", Gastroenterology, 159, pp.1290~1301 (2020)
32. Aminian A, "Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis", JAMA, 326, pp.2031~2042 (2021)
33. Rustgi VK, "Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity", gastroenterology, 161, pp.171~184 (2021)
34. Pedersen JS, "Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on non-alcoholic fatty liver disease : a 12-month follow-up study with paired liver biopsies", J Clin Med, 10, pp.3783~ (2021)
35. Jirapinyo P, "Effect of endoscopic bariatric and metabolic therapies on nonalcoholic fatty liver disease : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 20, pp.511~524 (2022)
36. Berzigotti A, "Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis", Hepatology, 54, pp.555~561 (2011)
37. Younus H, "Bariatric surgery in cirrhotic patients : is it safe?", Obes Surg, 30, pp.1241~1248 (2020)
38. Mosko JD, "Increased perioperative mortality following bariatric surgery among patients with cirrhosis", Clin Gastroenterol Hepatol, 9, pp.897~901 (2011)
39. Mumtaz K, "Bariatric surgery in patients with cirrhosis : careful patient and surgery-type selection is key to improving outcomes", Obes Surg, 30, pp.3444~3452 (2020)
40. Jan A, "A systematic review of bariatric surgery in patients with liver cirrhosis", Obes Surg, 25, pp.1518~1526 (2015)
41. Izzy M, "Bariatric surgery proves long-term benefit in patients with cirrhosis", Gastroenterol Rep(Oxf), 9, pp.252~256 (2020)
42. Patton H, "AGA clinical practice update on bariatric surgery in cirrhosis : expert review", Clin Gastroenterol Hepatol, 19, pp.436~445 (2021)
43. Reverter E, "The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery", J Hepatol, 71, pp.942~950 (2019)
44. Mendoza YP, "Malnutrition and alcohol in patients presenting with severe complications of cirrhosis after laparoscopic bariatric surgery", Obes Surg, 31, pp.2817~2822 (2021)
45. Takata MC, "Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation", Surg Obes Relat Dis, 4, pp.159~164 (2008)
46. Lin MY, "Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates", Surg Obes Relat Dis, 9, pp.653~658 (2013)
47. Lee Y, "Bariatric surgery before, during, and after liver transplantation : a systematic review and meta-analysis", Surg Obes Relat Dis, 16, pp.1336~1347 (2020)
48. Cotter TG, "Nonalcoholic steatohepatitis after liver transplantation", Liver Transpl, 26, pp.141~159 (2020)
49. Saeed N, "Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant : systematic review and meta-analysis", Transplantation, 103, pp.e345~e354 (2019)
50. Lopez-Lopez V, "Are we ready for bariatric surgery in a liver transplant program? a meta-analysis", Obes Surg, 31, pp.1214~1222 (2021)
51. Cheng YL, "Outcomes of bariatric surgery after solid organ transplantation", Obes Surg, 30, pp.4899~4904 (2020)
52. Ooi GJ, "Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease", Obes Surg, 27, pp.1533~1542 (2017)
53. Nickel F, "Bariatric surgery as an efficient treatment for non-alcoholic fatty liver disease in a prospective study with 1-year followup : BariScan study", Obes Surg, 28, pp.1342~1350 (2018)
54. Castera L, "Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease", Gastroenterology, 156, pp.1264~1281 (2019)
55. Geerts A, "The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery", Transplant Proc, 42, pp.4395~4398 (2010)
56. Mahawar KK, "Monitoring of liver function tests after Roux-enY gastric bypass : an examination of evidence base", Obes Surg, 26, pp.2516~2522 (2016)
57. European Association for the Study of the Liver, "EASL clinical practice guidelines on nutrition in chronic liver disease", J Hepatol, 70, pp.172~193 (2019)
58. King WC, "Prevalence of alcohol use disorders before and after bariatric surgery", JAMA, 307, pp.2516~2525 (2012)
59. Ibrahim N, "New onset alcohol use disorder following bariatric surgery", Surg Endosc, 33, pp.2521~2530 (2019)
60. Lefere S, "Bariatric surgery patients are at risk for alcoholic liver disease with need for liver transplantation", Obes Surg, 30, pp.4659~4664 (2020)
61. Van Melkebeke L, "Patients with a history of bariatric surgery are 8 years younger at presentation with severe alcoholic hepatitis", Obes Surg, 33, pp.284~292 (2023)
62. Mellinger JL, "Bariatric surgery and the risk of alcohol-related cirrhosis and alcohol misuse", Liver Int, 41, pp.1012~1019 (2021)

관련 논문AI추천